Biopharma Technology Limited

New vaccines are made from proteins that have to be injected using a needle. The process of making these proteins is very expensive and different for each vaccine. They cannot be put into tablets because they would be digested in the gut, and they need to be refrigerated and transported around developing countries via a distribution network called the col...

This project aims to assess the commercial opportunity for a new laboratory consumable product. Specifically, Biopharma Technologies Limited (Biopharma) have submitted a patent application describing a reagent tube that enables freeze drying of liquid reagents directly in industry standard ‘eppendorf’ style reagent tubes. At present, temperature-sensitive...

This project aims to develop novel bio insecticides from fusion proteins that deliver insecticidal toxins and across the target insect gut. The results of the project will be the creation of targeted fusion protein insecticides; this requires the development of processes for their economic production, acceleration of expression rate, and optimisation of a...

This project followed on from a previous TSB project that investigated the optimisation and stabilisation of probiotic material for incorporation into a capsule format. This project aims to build on this and develop a process to microencapsulate probiotic bacteria, allowing the delivery of a defined number of bacteria to the desired point of absorption, w...

The project aims to identify novel approaches to the processing and formulation of herbicides; that will enable enhanced bio-availability; this will allow lower application rates to be used without loss of efficacy. This will allow the same weed control action to be achieved with a lower rate of application, thus reducing overall environmental exposure. T...

Awaiting Public Summary